USPTO serial 87003192
ICAN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 23, 2018
- Examiner
- RIRIE, VERNA BETH
- Law office
- FILE DESTROYED
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ICAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*
Plus Government fees of $3,900
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
International Cancer Advocacy Network
Phoenix, AZ
Other trademarks owned by International Cancer Advocacy Network
International Cancer Advocacy Network
Phoenix, AZ
Other trademarks owned by International Cancer Advocacy Network
International Cancer Advocacy Network
Phoenix, AZ
Other trademarks owned by International Cancer Advocacy Network
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan Stone Rosenfield
Susan Stone Rosenfield FENNEMORE CRAIG, P.C.2394 EAST CAMELBACK ROADSUITE 600PHOENIX, AZ 85016-3429Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Lobbying services, namely, promoting the interests of cancer patients, cancer researchers, cancer treatment providers, and others involved with cancer research, diagnosis and treatment; providing information in the field of patient-payor communications in which information regarding medical billing can be exchanged; providing information in the field of government affairs related to the expanded access to experimental cancer drugs for compassionate use; providing physician and medical specialist referrals to patients fighting chronic diseases and lethal diseases for assisting in the access to second opinions; providing information in the nature of discounts and rebates for cancer patients for diagnostic tests, drugs and medical devices | ACTIVE | — |
| 036 | Charitable fundraising to support providing educational services and information about prevention, screening, diagnosis and treatment of cancer, cancer patient navigation services, cancer patient and clinical trials advocacy programs, research, development and regulatory approval of methods, drugs and devices for prevention, screening, diagnosis and treatment of cancer, lobbying and legislation regarding cancer-related issues, patient-provider communications, and patient-payor communications; providing information concerning the patient's financial reimbursement from medical insurers and patient assistance programs in the nature of cost-mitigating health reimbursement arrangements for cancer treatment; providing information regarding insurance coverage and patient assistance programs in the nature of cost-mitigating health reimbursement arrangements for cancer patients for diagnostic tests, drugs and medical devices | ACTIVE | — |
| 041 | Co-sponsoring and providing educational conferences, both live and via telephone conferences, seminars, classes and workshops in the field of cancer-related issues and distribution of educational materials in connection therewith; on-line journals, namely, blogs featuring information in the field of cancer-related issues; providing podcasts and non-downloadable videos in the field of cancer-related issues; providing on-line journals, namely, blogs featuring cancer-related issues and postings in honor of patients and in memory of patients | ACTIVE | — |
| 042 | Providing information in the field of anti-cancer drug discovery and development; providing information in the field of clinical trials | ACTIVE | — |
| 044 | Providing information about prevention, screening, diagnosis and treatment of cancer; providing a website, and links to the websites of others, featuring information about prevention, screening, diagnosis and treatment of cancer; providing information in the field of patient medical information where patients can inquire about medical issues and be directed to resources for medical information customized to their need for information about their condition; providing information in the field of cancer prevention, screening, diagnosis and treatment; providing information in the field of cancer treatment for the benefit of patients and patients' families; providing information in the field of communications between patients and health care providers in which patient medical information can be exchanged; providing information in the field of patient access to diagnostic tests, drugs and medical devices provided by health care facilities; providing information in the field of medicine, personalized medicine, pathology, oncology, interventional radiology, radiogenomics, and anesthesiology; providing information in the field of complementary and alternative medicine for use in the prevention and treatment of cancer; providing access to medical specialists for second opinions for patients fighting chronic diseases and lethal diseases | ACTIVE | — |
| 045 | Providing patient advocacy and patient advocate services in the field of cancer treatment; providing cancer patient advocacy programs; providing advocacy services to potential participants and participants in clinical trials; providing information in the field of personal emotional support of cancer patients and patients' families; providing information in the field of regulatory affairs compliance relating to the approval of anticancer compounds in the U.S. and abroad | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by International Cancer Advocacy Network
- Other trademarks owned by International Cancer Advocacy Network
- Other trademarks owned by International Cancer Advocacy Network
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named ICAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 27, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 27, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 12, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jan 23, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 23, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 7, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 7, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 18, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 16, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 7, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 19, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 19, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 19, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 3, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 2, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 2, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 3, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 21, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Apr 20, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 19, 2016 | NWAP | NEW APPLICATION ENTERED | — |